human tumour xenografts
Recently Published Documents


TOTAL DOCUMENTS

107
(FIVE YEARS 4)

H-INDEX

25
(FIVE YEARS 1)

2020 ◽  
Author(s):  
Kok-Siong Chen ◽  
Zorana Lynton ◽  
Jonathan W C Lim ◽  
Thomas Robertson ◽  
Richard M Gronostajski ◽  
...  

Abstract Nuclear factor one (NFI) transcription factors are implicated in both brain development and cancer in mice and humans and play an essential role in glial differentiation. NFI expression is reduced in human astrocytoma samples, particularly those of higher grade, whereas over-expression of NFI protein can induce the differentiation of glioblastoma cells within human tumour xenografts and in glioblastoma cell lines in vitro. These data indicate that NFI proteins may act as tumour suppressors in glioma. To test this hypothesis, we generated complex mouse genetic crosses involving six alleles to target gene deletion of known tumour suppressor genes that induce endogenous high-grade glioma in mice, and overlaid this with loss of function Nfi mutant alleles, Nfia and Nfib, a reporter transgene and an inducible Cre allele. Deletion of Nfi resulted in reduced survival time of the mice, increased tumour load and a more aggressive tumour phenotype than observed in glioma mice with normal expression of NFI. Together, these data indicate that NFI genes represent a credible target for both diagnostic analyses and therapeutic strategies to combat high-grade glioma.


2020 ◽  
Vol 13 (7) ◽  
pp. dmm044586 ◽  
Author(s):  
Lukas Krasny ◽  
Philip Bland ◽  
Jessica Burns ◽  
Nadia Carvalho Lima ◽  
Peter T. Harrison ◽  
...  

ABSTRACTSWATH-mass spectrometry (MS) enables accurate and reproducible proteomic profiling in multiple model organisms including the mouse. Here, we present a comprehensive mouse reference spectral library (MouseRefSWATH) that permits quantification of up to 10,597 proteins (62.2% of the mouse proteome) by SWATH-MS. We exploit MouseRefSWATH to develop an analytical pipeline for species-specific deconvolution of proteomic alterations in human tumour xenografts (XenoSWATH). This method overcomes the challenge of high sequence similarity between mouse and human proteins, facilitating the study of host microenvironment-tumour interactions from ‘bulk tumour’ measurements. We apply the XenoSWATH pipeline to characterize an intraductal xenograft model of breast ductal carcinoma in situ and uncover complex regulation consistent with stromal reprogramming, where the modulation of cell migration pathways is not restricted to tumour cells but also operates in the mouse stroma upon progression to invasive disease. MouseRefSWATH and XenoSWATH open new opportunities for in-depth and reproducible proteomic assessment to address wide-ranging biological questions involving this important model organism.


2020 ◽  
Author(s):  
Lukas Krasny ◽  
Philip Bland ◽  
Jessica Burns ◽  
Nadia Carvalho Lima ◽  
Peter T. Harrison ◽  
...  

AbstractSWATH-mass spectrometry (MS) enables accurate and reproducible proteomic profiling in multiple model organisms including the mouse. Here we present a comprehensive mouse reference spectral library (MouseRefSWATH) that permits quantification of up to 10,597 proteins (62.2% of the mouse proteome) by SWATH-MS. We exploit MouseRefSWATH to develop an analytical pipeline for species-specific deconvolution of proteomic alterations in human tumour xenografts (XenoSWATH). This method overcomes the challenge of high sequence similarity between mouse and human proteins, facilitating the study of host microenvironment-tumour interactions from ‘bulk tumour’ measurements. We apply the XenoSWATH pipeline to characterise an intraductal xenograft model of breast ductal carcinoma in-situ and uncover complex regulation of cell migration pathways that are not restricted to tumour cells but also operate in the mouse stroma upon progression to invasive disease. MouseRefSWATH and XenoSWATH opens new opportunities for in-depth and reproducible proteomic assessment to address wide-ranging biological questions involving this important model organism.


2015 ◽  
Vol 112 (5) ◽  
pp. 832-840 ◽  
Author(s):  
Q Tan ◽  
A M Joshua ◽  
J K Saggar ◽  
M Yu ◽  
M Wang ◽  
...  

Angiogenesis ◽  
2012 ◽  
Vol 15 (4) ◽  
pp. 555-568 ◽  
Author(s):  
Matthew Farren ◽  
Susie Weston ◽  
Helen Brown ◽  
Nicola Broadbent ◽  
Steve Powell ◽  
...  

2011 ◽  
Vol 64 (5) ◽  
pp. 625 ◽  
Author(s):  
Wei Wang ◽  
Arlin G. Cameron ◽  
Juliet A. Wendt ◽  
Michel E. Mawad ◽  
Shi Ke

In vivo optical imaging methods have become a cornerstone of pre-clinical cancer research. Genetically modified cells with fluorescent or bioluminescent reporters allow researchers to non-invasively study tumour proliferation and biochemistry over time. Target-specific fluorescent probes may be used to reveal specific tumour properties such as growth patterns, neovasculature formation, and compartmental probe absorbance. Herein, we demonstrate the simultaneous optical imaging of these tumour properties in a human neuroblastoma model. We used luciferase-positive cancer cells, a neovasculature specific fluorescent probe, and a fluorescent tumour cell target-specific agent, in conjunction with X-ray/CT for anatomical localization. These experiments revealed a detailed map of the tumour progression and biological interactions with imaging agents within the tumour.


Sign in / Sign up

Export Citation Format

Share Document